1. Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.
- Author
-
Lux MC, Standke LC, and Tan DS
- Subjects
- Adenosine Monophosphate chemistry, Drug Design, Enzyme Inhibitors chemistry, Models, Molecular, Protein Conformation, Adenosine Monophosphate analogs & derivatives, Adenosine Monophosphate biosynthesis, Enzyme Inhibitors pharmacology, Ligases antagonists & inhibitors, Ligases classification
- Abstract
Adenylate-forming enzymes are a mechanistic superfamily that are involved in diverse biochemical pathways. They catalyze ATP-dependent activation of carboxylic acid substrates as reactive acyl adenylate (acyl-AMP) intermediates and subsequent coupling to various nucleophiles to generate ester, thioester, and amide products. Inspired by natural products, acyl sulfonyladenosines (acyl-AMS) that mimic the tightly bound acyl-AMP reaction intermediates have been developed as potent inhibitors of adenylate-forming enzymes. This simple yet powerful inhibitor design platform has provided a wide range of biological probes as well as several therapeutic lead compounds. Herein, we provide an overview of the nine structural classes of adenylate-forming enzymes and examples of acyl-AMS inhibitors that have been developed for each.
- Published
- 2019
- Full Text
- View/download PDF